It's true that a Sharpe ratio of 3.15 is generally seen as strong evidence of robust performance, yet we must consider the mandate under which these systems operate. This holds true only if the model's exit conditions are clearly defined and adhere to strict regulatory compliance, as unexpected shifts in capital adequacy rules can quickly undermine even the most promising backtested results, regardless of how stable the market environment was during the testing period. Before conviction, downside.